Biogen (BIIB) Total Debt (2009 - 2026)

Biogen has reported Total Debt for 18 years, with the latest figure at $8.1 billion in Q2 2026.

• On a quarterly basis, Total Debt rose 25.75% year-over-year to $8.1 billion in Q2 2026; TTM through Jun 2026 was $8.1 billion, a 25.75% increase from a year earlier, with the FY2025 full-year figure at $6.3 billion, down 21.85% from the prior year.
• Total Debt was $8.1 billion for Q2 2026 at Biogen, up from $6.3 billion in the prior quarter.
• The five-year high for Total Debt was $8.3 billion in Q2 2022, with the low at $6.3 billion in Q3 2022.
• Average Total Debt over 5 years is $7.0 billion, with a median of $6.6 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Total Debt declined 24.07% in 2023, then rose 25.75% in 2026.
• Over 5 years, Total Debt stood at $6.3 billion in 2022, then gained by 12.85% to $7.1 billion in 2023, then climbed by 13.49% to $8.0 billion in 2024, then dropped by 21.85% to $6.3 billion in 2025, then advanced by 28.69% to $8.1 billion in 2026.
• The last three Total Debt figures came in at $8.1 billion (Q2 2026), $6.3 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.